We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dr. Martens Plc | LSE:DOCS | London | Ordinary Share | GB00BL6NGV24 | ORD GBP0.01 |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
72.85 | 73.25 | 74.25 | 70.20 | 70.20 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Footwear-wholesale | 877.1M | 69.2M | 0.0718 | 24.79 | 683.7M |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
16:47:02 | O | 29 | 72.90 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
15/1/2025 | 18:14 | UK RNS | Dr. Martens PLC Director/PDMR Shareholding |
02/1/2025 | 12:02 | UK RNS | Dr. Martens PLC Total Voting Rights |
20/12/2024 | 15:07 | UK RNS | Dr. Martens PLC Holding(s) in Company |
13/12/2024 | 11:54 | UK RNS | Dr. Martens PLC Director/PDMR Shareholding |
12/12/2024 | 07:00 | UK RNS | Dr. Martens PLC Block Listing Application |
02/12/2024 | 10:43 | UK RNS | Dr. Martens PLC Block listing Interim Review |
02/12/2024 | 10:10 | UK RNS | Dr. Martens PLC Total Voting Rights |
28/11/2024 | 07:01 | UK RNS | Dr. Martens PLC Confirmation of new CEO start date |
28/11/2024 | 07:00 | UK RNS | Dr. Martens PLC Half-year Report |
12/11/2024 | 15:56 | UK RNS | Dr. Martens PLC Director/PDMR Shareholding |
Dr. Martens (DOCS) Share Charts1 Year Dr. Martens Chart |
|
1 Month Dr. Martens Chart |
Intraday Dr. Martens Chart |
Date | Time | Title | Posts |
---|---|---|---|
13/12/2024 | 16:19 | Dr. Martens | 862 |
22/4/2024 | 06:15 | Dr Martens - just mucking about (please ignore) | 11 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 26/1/2025 08:20 by Dr. Martens Daily Update Dr. Martens Plc is listed in the Footwear-wholesale sector of the London Stock Exchange with ticker DOCS. The last closing price for Dr. Martens was 70.90p.Dr. Martens currently has 964,319,766 shares in issue. The market capitalisation of Dr. Martens is £1,716,489,183. Dr. Martens has a price to earnings ratio (PE ratio) of 24.79. This morning DOCS shares opened at 70.20p |
Posted at 13/12/2024 16:19 by the white house Bought this years pair yesterday, passed buyers on their way out, which was nice. sales staff stating business ahead of last year when they had stock issues but now resolved and plenty of ammo for this year and all is well ahead had a strong morning by 11am Online sales look decent with top couple of pairs selling 350 between them daily & interesting to note that these best sellers are in the highest price bracket of 170 & 180 pounds which can't be a bad thing |
Posted at 10/12/2024 15:58 by velocytongo I know it’s only anecdotal but London and Paris are doing well. There were some amazing offers on Black Friday (I bot another pair of Crewsons) and my daughter got a 20% discount for trading in an old pair.The new ranges are all designed with a soft leather and lighter sole and all have a two yr guarantee. The comfort is critical if Docs want to compete with trainers. |
Posted at 07/12/2024 17:47 by hamhamham1 HAMHAMHAM1 RAISES DR. MARTENS PRICE TARGET TO 150 (90) PENCE - 'PUT THE BOOT IN HERE!' |
Posted at 06/12/2024 16:15 by velocytongo I doubled down after the institutional sale so my entry price is much nearer 70p than a £1! |
Posted at 23/9/2024 07:48 by pireric Should rename the company to Dog Martens in sympathy with the share price performance since IPOEric |
Posted at 21/9/2024 12:21 by ih_538656 Dave, I would say SDG as a potential recovery play (much smaller size!) could be interesting - however their H1 outlook (16 October) may be dire.Having aggressively rolled out physical space makes DOCS a more challenging situation. Their price point with cheaper non branded 'substitutes' available also a headwind. |
Posted at 20/9/2024 14:22 by tomboyb DOCs net debt going in the wrong direction -And cash depreciating - Overall results this year will therefore be very second-half weighted, particularly from a profit perspective. Share price may well be very telling here - |
Posted at 16/7/2024 13:52 by mr5k Burberry's issues are very different from Docs. High-end consumer brands have pushed prices beyond inflation for so long that many buyers have said enough. Also, BRBY was trying to elevate the brand to Dior and Versace levels and that has not worked.I own a BRBY trench coat that cost me £120 25 years ago (as did many colleagues where I worked). That same coat now costs £1,500. Docs pricing is not out of whack with the price of other branded boots (Blundstones (a little more), Birkenstocks (more expensive) Russell and Bromley (even more expensive) and the price points are accessible. In terms of Asian exposure, Japan and S Korea are performing well (atm) and they closed their operations in China. BRBY is particularly exposed to the latter in terms of direct sales and London, where the duty-free sales benefit was dumped by the Tories (another Brexit benefit). Docs problems are in the US where the brand is less well established and the market is not as deep as management anticpated. |
Posted at 17/4/2024 10:50 by itisonlymoney darrin, thanks for the detail on the new ceo. Btw, does that look like the profile for a good fashion brand ceo? Big salary maybe. I have doubts. a senior director for apple retail - he's had lots of people around him to generate any success there. snr directors like to take all the credit if things go well, but out on their own, they often fail, so he's an unknown quantity at this point. does anyone here know how he did at wolf olins?huckers, I've asked the same question. my instinct atm is that this fifth profit warning and the change of leadership (a necessary move) with an untested ceo who has apparently been on the board (as a non-exec rather than ops management) throughout this car crash, creates massive uncertainty on top of the forecast for much lower profits. there's nothing but shifting sand under the strategy and the forecasts, plus the global environment does not look good - major european war which it looks like russia will now win, and the prospect of a middle eastern war. Docs has a high valuation based on its brand appeal but the retail market is not validating that appeal by buying the boots in huge numbers, so i think the share price has to reflect actual profit without a brand premium. that's my thinking and that leads me to guess that the share price is going steadily down for sometime now. i haven't got the confidence in that prediction to actually short the shares though, because there's no telling when a bid for the company could come. right now i'm watching. if the share price gets to 30p, i will almost certainly be a buyer. |
Posted at 28/11/2022 14:32 by essentialinvestor As the DOCS share price is given to large % moves in either direction, there are likelyto be ample trading opportunities for those astute/lucky enough to catch some of those. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions